Cairo hosted the Rare Disease Patient Support Groups Summit on 20 April for two days, bringing together representatives from the Ministry of Health and Population, the National Council for Childhood and Motherhood, the World Health Organization (WHO), UNICEF, and leading health experts.
The World Health Organization defines rare diseases as conditions that affect a small proportion of the population, fewer than 1 in 2,000 people, although definitions may vary by country. Examples include cystic fibrosis, haemophilia, sickle cell disease, and certain genetic disorders, many of which are chronic, progressive, and require specialized care.
The event was organized in collaboration with the private sector pharmaceutical AstraZeneca and civil society institutions, marking a first-of-its-kind initiative in the Middle East and Africa focused on strengthening patient support systems for rare diseases.
The summit focused on improving outcomes for patients with rare conditions, with emphasis on early diagnosis, better referral systems, and integrated care models.
Discussions highlighted the complexity of rare diseases, which often require specialized diagnostic tools, multidisciplinary treatment approaches, and long-term follow-up.
Participants said delayed diagnosis remains one of the main challenges for patients, often leading to complications that could be reduced through greater awareness and improved screening systems.
A key focus of the event was the importance of building accurate and comprehensive health data. Experts underlined that the absence of unified patient registries limits the ability of healthcare systems to plan effectively and allocate resources.
Strengthening national databases, they noted, would support evidence-based decision-making and improve access to timely and appropriate treatment.
The summit also called for standardised treatment protocols for rare diseases. Differences in care approaches can affect outcomes, making it important to establish clear clinical guidelines to ensure consistency across providers. Integrating these standards into the national health system was identified as essential for improving equity in care.
Another major theme was the role of patient support groups in improving health outcomes. These groups provide not only emotional and social support but also play a growing role in raising awareness, advocating for patient rights, and contributing to health policy discussions.
Strengthening their organizational and communication capacities was highlighted as essential to enabling them to act as effective partners within the healthcare ecosystem.
The discussions also emphasized prevention and public awareness. Increasing knowledge among healthcare professionals and the wider public can lead to earlier recognition of symptoms and faster referral to specialised care.
International organizations participating in the summit shared best practices and global experiences, reinforcing the importance of collaboration in addressing rare diseases.
The event reflects Egypt’s growing focus on rare diseases as a public health priority. By bringing together government bodies, international organizations, and civil society, the summit aimed to support a more coordinated and sustainable approach to care, improving quality of life for patients and their families.
Short link: